메뉴 건너뛰기




Volumn 35, Issue , 2015, Pages 73-77

Metabolomics in pharmaceutical research and development

Author keywords

[No Author keywords available]

Indexed keywords

PATIENT TREATMENT;

EID: 84927729873     PISSN: 09581669     EISSN: 18790429     Source Type: Journal    
DOI: 10.1016/j.copbio.2015.04.004     Document Type: Review
Times cited : (54)

References (63)
  • 1
    • 50249099816 scopus 로고    scopus 로고
    • Metabolic phenotyping in health and disease
    • Holmes E., Wilson I.D., Nicholson J.K. Metabolic phenotyping in health and disease. Cell 2008, 134:714-717.
    • (2008) Cell , vol.134 , pp. 714-717
    • Holmes, E.1    Wilson, I.D.2    Nicholson, J.K.3
  • 2
    • 33750719994 scopus 로고    scopus 로고
    • Global systems biology, personalized medicine and molecular epidemiology
    • Nicholson J.K. Global systems biology, personalized medicine and molecular epidemiology. Mol Syst Biol 2006, 2:52.
    • (2006) Mol Syst Biol , vol.2 , pp. 52
    • Nicholson, J.K.1
  • 3
    • 84883158538 scopus 로고    scopus 로고
    • Metabolomics in plants and humans: applications in the prevention and diagnosis of diseases
    • Gomez-Casati D.F., Zanor M.I., Busi M.V. Metabolomics in plants and humans: applications in the prevention and diagnosis of diseases. Biomed Res Int 2013, 7925-7927.
    • (2013) Biomed Res Int , pp. 7925-7927
    • Gomez-Casati, D.F.1    Zanor, M.I.2    Busi, M.V.3
  • 4
    • 84904116803 scopus 로고    scopus 로고
    • Microbial metabolomics: innovation, application, insight
    • Aldridge B.B., Rhee K.Y. Microbial metabolomics: innovation, application, insight. Curr Opin Microbiol 2014, 19:90-96.
    • (2014) Curr Opin Microbiol , vol.19 , pp. 90-96
    • Aldridge, B.B.1    Rhee, K.Y.2
  • 5
    • 84906075660 scopus 로고    scopus 로고
    • An emerging role for metabolomics in nutrition science
    • Astarita G., Langridge J. An emerging role for metabolomics in nutrition science. J Nutrigenet Nutrigenomics 2013, 6:181-200.
    • (2013) J Nutrigenet Nutrigenomics , vol.6 , pp. 181-200
    • Astarita, G.1    Langridge, J.2
  • 7
    • 33846977711 scopus 로고    scopus 로고
    • Metabonomics in pharmaceutical R&D
    • Lindon J.C., Holmes E., Nicholson J.K. Metabonomics in pharmaceutical R&D. FEBS J 2007, 274:1140-1151.
    • (2007) FEBS J , vol.274 , pp. 1140-1151
    • Lindon, J.C.1    Holmes, E.2    Nicholson, J.K.3
  • 8
    • 84892374338 scopus 로고    scopus 로고
    • Biomarkers in pharmacology and drug discovery
    • Anderson D.C., Kodukula K. Biomarkers in pharmacology and drug discovery. Biochem Pharmacol 2014, 87:172-188.
    • (2014) Biochem Pharmacol , vol.87 , pp. 172-188
    • Anderson, D.C.1    Kodukula, K.2
  • 10
    • 84889591862 scopus 로고    scopus 로고
    • Metabolomics in cancer biomarker discovery: current trends and future perspectives
    • Armitage E.G., Barbas C. Metabolomics in cancer biomarker discovery: current trends and future perspectives. J Pharm Biomed Anal 2014, 87:1-11.
    • (2014) J Pharm Biomed Anal , vol.87 , pp. 1-11
    • Armitage, E.G.1    Barbas, C.2
  • 11
    • 13244266921 scopus 로고    scopus 로고
    • Lead- and drug-like compounds: the rule-of-five revolution
    • Lipinski C.A. Lead- and drug-like compounds: the rule-of-five revolution. Drug Discov Today Technol 2004, 1:337-341.
    • (2004) Drug Discov Today Technol , vol.1 , pp. 337-341
    • Lipinski, C.A.1
  • 12
    • 24944547571 scopus 로고    scopus 로고
    • Why drugs fail-a study on side effects in new chemical entities
    • Schuster D., Laggner C., Langer T. Why drugs fail-a study on side effects in new chemical entities. Curr Pharm Des 2005, 11:3545-3559.
    • (2005) Curr Pharm Des , vol.11 , pp. 3545-3559
    • Schuster, D.1    Laggner, C.2    Langer, T.3
  • 13
    • 84857784212 scopus 로고    scopus 로고
    • Cancer biomarkers: selecting the right drug for the right patient
    • Kelloff G.J., Sigman C.C. Cancer biomarkers: selecting the right drug for the right patient. Nat Rev Drug Discov 2012, 11:201-214.
    • (2012) Nat Rev Drug Discov , vol.11 , pp. 201-214
    • Kelloff, G.J.1    Sigman, C.C.2
  • 14
    • 84858631197 scopus 로고    scopus 로고
    • Pharmaco-metabolomics: an emerging "omics" tool for the personalization of anticancer treatments and identification of new valuable therapeutic targets
    • Corona G., Rizzolio F., Giordano A., Toffoli G. Pharmaco-metabolomics: an emerging "omics" tool for the personalization of anticancer treatments and identification of new valuable therapeutic targets. J Cell Physiol 2012, 227:2827-2831.
    • (2012) J Cell Physiol , vol.227 , pp. 2827-2831
    • Corona, G.1    Rizzolio, F.2    Giordano, A.3    Toffoli, G.4
  • 15
    • 79953646618 scopus 로고    scopus 로고
    • Metabolomics and its practical value in pharmaceutical industry
    • Wei R. Metabolomics and its practical value in pharmaceutical industry. Curr Drug Metab 2011, 12:345-358.
    • (2011) Curr Drug Metab , vol.12 , pp. 345-358
    • Wei, R.1
  • 16
    • 84871721219 scopus 로고    scopus 로고
    • Metabolomics and its potential in drug development
    • Beyoglu D., Idle J.R. Metabolomics and its potential in drug development. Biochem Pharmacol 2013, 85:12-20.
    • (2013) Biochem Pharmacol , vol.85 , pp. 12-20
    • Beyoglu, D.1    Idle, J.R.2
  • 17
    • 84908341419 scopus 로고    scopus 로고
    • Metabolomics in cell culture-a strategy to study crucial metabolic pathways in cancer development and the response to treatment
    • Halama A. Metabolomics in cell culture-a strategy to study crucial metabolic pathways in cancer development and the response to treatment. Arch Biochem Biophys 2014, 10.1016/j.abb.2014.09.002.
    • (2014) Arch Biochem Biophys
    • Halama, A.1
  • 18
    • 84919460853 scopus 로고    scopus 로고
    • Metabolomics: a window into the adaptive physiology of Mycobacterium tuberculosis
    • Eoh H. Metabolomics: a window into the adaptive physiology of Mycobacterium tuberculosis. Tuberculosis (Edinb) 2014, 10.1016/j.tube.2014.08.002.
    • (2014) Tuberculosis (Edinb)
    • Eoh, H.1
  • 19
    • 79952937101 scopus 로고    scopus 로고
    • H HRMAS NMR derived bio-markers related to tumor grade, tumor cell fraction, and cell proliferation in prostate tissue samples
    • Stenman K., Stattin P., Stenlund H., Riklund K., Grobner G., Bergh A. H HRMAS NMR derived bio-markers related to tumor grade, tumor cell fraction, and cell proliferation in prostate tissue samples. Biomark Insights 2011, 6:39-47.
    • (2011) Biomark Insights , vol.6 , pp. 39-47
    • Stenman, K.1    Stattin, P.2    Stenlund, H.3    Riklund, K.4    Grobner, G.5    Bergh, A.6
  • 24
    • 84858064590 scopus 로고    scopus 로고
    • UPLC-MS metabolic profiling of second trimester amniotic fluid and maternal urine and comparison with NMR spectral profiling for the identification of pregnancy disorder biomarkers
    • Graca G., Goodfellow B.J., Barros A.S., Diaz S., Duarte I.F., Spagou K., Veselkov K., Want E.J., Lindon J.C., Carreira I.M., et al. UPLC-MS metabolic profiling of second trimester amniotic fluid and maternal urine and comparison with NMR spectral profiling for the identification of pregnancy disorder biomarkers. Mol Biosyst 2012, 8:1243-1254.
    • (2012) Mol Biosyst , vol.8 , pp. 1243-1254
    • Graca, G.1    Goodfellow, B.J.2    Barros, A.S.3    Diaz, S.4    Duarte, I.F.5    Spagou, K.6    Veselkov, K.7    Want, E.J.8    Lindon, J.C.9    Carreira, I.M.10
  • 28
    • 80051682403 scopus 로고    scopus 로고
    • Advances in metabolite identification
    • Wishart D.S. Advances in metabolite identification. Bioanalysis 2011, 3:1769-1782.
    • (2011) Bioanalysis , vol.3 , pp. 1769-1782
    • Wishart, D.S.1
  • 29
    • 78650761774 scopus 로고    scopus 로고
    • Nanostructure-initiator mass spectrometry metabolite analysis and imaging
    • Greving M.P., Patti G.J., Siuzdak G. Nanostructure-initiator mass spectrometry metabolite analysis and imaging. Anal Chem 2011, 83:2-7.
    • (2011) Anal Chem , vol.83 , pp. 2-7
    • Greving, M.P.1    Patti, G.J.2    Siuzdak, G.3
  • 30
    • 17444404226 scopus 로고    scopus 로고
    • High resolution "ultra performance" liquid chromatography coupled to oa-TOF mass spectrometry as a tool for differential metabolic pathway profiling in functional genomic studies
    • Wilson I.D., Nicholson J.K., Castro-Perez J., Granger J.H., Johnson K.A., Smith B.W., Plumb R.S. High resolution "ultra performance" liquid chromatography coupled to oa-TOF mass spectrometry as a tool for differential metabolic pathway profiling in functional genomic studies. J Proteome Res 2005, 4:591-598.
    • (2005) J Proteome Res , vol.4 , pp. 591-598
    • Wilson, I.D.1    Nicholson, J.K.2    Castro-Perez, J.3    Granger, J.H.4    Johnson, K.A.5    Smith, B.W.6    Plumb, R.S.7
  • 32
    • 84867250802 scopus 로고    scopus 로고
    • Application of NMR metabolomics to search for human disease biomarkers
    • Gebregiworgis T., Powers R. Application of NMR metabolomics to search for human disease biomarkers. Comb Chem High Throughput Screen 2013, 15:595-610.
    • (2013) Comb Chem High Throughput Screen , vol.15 , pp. 595-610
    • Gebregiworgis, T.1    Powers, R.2
  • 33
    • 34249890793 scopus 로고    scopus 로고
    • Metabolomics as a complementary tool in cell culture
    • Khoo S.H., Al-Rubeai M. Metabolomics as a complementary tool in cell culture. Biotechnol Appl Biochem 2007, 47:71-84.
    • (2007) Biotechnol Appl Biochem , vol.47 , pp. 71-84
    • Khoo, S.H.1    Al-Rubeai, M.2
  • 36
    • 84860424349 scopus 로고    scopus 로고
    • Metabonomic study of host-phage interaction by nuclear magnetic resonance- and statistical total correlation spectroscopy-based analysis
    • Sonkar K., Purusottam R.N., Sinha N. Metabonomic study of host-phage interaction by nuclear magnetic resonance- and statistical total correlation spectroscopy-based analysis. Anal Chem 2012, 84:4063-4070.
    • (2012) Anal Chem , vol.84 , pp. 4063-4070
    • Sonkar, K.1    Purusottam, R.N.2    Sinha, N.3
  • 37
    • 84905046901 scopus 로고    scopus 로고
    • The current state of drug discovery and a potential role for NMR metabolomics
    • Powers R. The current state of drug discovery and a potential role for NMR metabolomics. J Med Chem 2014, 57:5860-5870.
    • (2014) J Med Chem , vol.57 , pp. 5860-5870
    • Powers, R.1
  • 39
    • 84883452088 scopus 로고    scopus 로고
    • Applications of metabolomics in drug discovery, development and theranostics
    • Cuperlovic-Culf M., Culf A.S., Morin P.J., Touaibia M. Applications of metabolomics in drug discovery, development and theranostics. Curr Metab 2013, 1:41-57.
    • (2013) Curr Metab , vol.1 , pp. 41-57
    • Cuperlovic-Culf, M.1    Culf, A.S.2    Morin, P.J.3    Touaibia, M.4
  • 40
    • 84888011244 scopus 로고    scopus 로고
    • Network-based approaches in drug discovery and early development
    • Harrold J.M., Ramanathan M., Mager D.E. Network-based approaches in drug discovery and early development. Clin Pharmacol Ther 2013, 94:651-658.
    • (2013) Clin Pharmacol Ther , vol.94 , pp. 651-658
    • Harrold, J.M.1    Ramanathan, M.2    Mager, D.E.3
  • 41
    • 84855870922 scopus 로고    scopus 로고
    • Potential drug targets on insomnia and intervention effects of Jujuboside A through metabolic pathway analysis as revealed by UPLC/ESI-SYNAPT-HDMS coupled with pattern recognition approach
    • Wang X., Yang B., Zhang A., Sun H., Yan G. Potential drug targets on insomnia and intervention effects of Jujuboside A through metabolic pathway analysis as revealed by UPLC/ESI-SYNAPT-HDMS coupled with pattern recognition approach. J Proteomics 2012, 75:1411-1427.
    • (2012) J Proteomics , vol.75 , pp. 1411-1427
    • Wang, X.1    Yang, B.2    Zhang, A.3    Sun, H.4    Yan, G.5
  • 42
    • 84890499902 scopus 로고    scopus 로고
    • Metabolomics reveal d-alanine:d-alanine ligase as the target of d-cycloserine in Mycobacterium tuberculosis
    • Prosser G.A., de Carvalho L.P. Metabolomics reveal d-alanine:d-alanine ligase as the target of d-cycloserine in Mycobacterium tuberculosis. ACS Med Chem Lett 2013, 4:1233-1237.
    • (2013) ACS Med Chem Lett , vol.4 , pp. 1233-1237
    • Prosser, G.A.1    de Carvalho, L.P.2
  • 43
    • 34548065407 scopus 로고    scopus 로고
    • Application of metabonomics in drug development
    • Keun H.C., Athersuch T.J. Application of metabonomics in drug development. Pharmacogenomics 2007, 8:731-741.
    • (2007) Pharmacogenomics , vol.8 , pp. 731-741
    • Keun, H.C.1    Athersuch, T.J.2
  • 44
    • 38049041308 scopus 로고    scopus 로고
    • Use of NMR metabolomics to analyze the targets of D-cycloserine in mycobacteria: role of D-alanine racemase
    • Halouska S., Chacon O., Fenton R.J., Zinniel D.K., Barletta R.G., Powers R. Use of NMR metabolomics to analyze the targets of D-cycloserine in mycobacteria: role of D-alanine racemase. J Proteome Res 2007, 6:4608-4614.
    • (2007) J Proteome Res , vol.6 , pp. 4608-4614
    • Halouska, S.1    Chacon, O.2    Fenton, R.J.3    Zinniel, D.K.4    Barletta, R.G.5    Powers, R.6
  • 45
    • 84856162572 scopus 로고    scopus 로고
    • Predicting the in vivo mechanism of action for drug leads using NMR metabolomics
    • Halouska S., Fenton R.J., Barletta R.G., Powers R. Predicting the in vivo mechanism of action for drug leads using NMR metabolomics. ACS Chem Biol 2012, 7:166-171.
    • (2012) ACS Chem Biol , vol.7 , pp. 166-171
    • Halouska, S.1    Fenton, R.J.2    Barletta, R.G.3    Powers, R.4
  • 48
    • 84893490530 scopus 로고    scopus 로고
    • Quality markers addressing preanalytical variations of blood and plasma processing identified by broad and targeted metabolite profiling
    • Kamlage B., Maldonado S.G., Bethan B., Peter E., Schmitz O., Liebenberg V., Schatz P. Quality markers addressing preanalytical variations of blood and plasma processing identified by broad and targeted metabolite profiling. Clin Chem 2014, 60:399-412.
    • (2014) Clin Chem , vol.60 , pp. 399-412
    • Kamlage, B.1    Maldonado, S.G.2    Bethan, B.3    Peter, E.4    Schmitz, O.5    Liebenberg, V.6    Schatz, P.7
  • 51
    • 84868095958 scopus 로고    scopus 로고
    • A metabonomics approach as a means for identification of potential biomarkers for early diagnosis of endometriosis
    • Dutta M., Joshi M., Srivastava S., Lodh I., Chakravarty B., Chaudhury K. A metabonomics approach as a means for identification of potential biomarkers for early diagnosis of endometriosis. Mol Biosyst 2012, 8:3281-3287.
    • (2012) Mol Biosyst , vol.8 , pp. 3281-3287
    • Dutta, M.1    Joshi, M.2    Srivastava, S.3    Lodh, I.4    Chakravarty, B.5    Chaudhury, K.6
  • 52
    • 84892153260 scopus 로고    scopus 로고
    • Applications of metabolomics in cancer research
    • Vermeersch K.A., Styczynski M.P. Applications of metabolomics in cancer research. J Carcinog 2013, 12:9.
    • (2013) J Carcinog , vol.12 , pp. 9
    • Vermeersch, K.A.1    Styczynski, M.P.2
  • 53
    • 80655131103 scopus 로고    scopus 로고
    • The cardiovascular risk of healthy individuals studied by NMR metabonomics of plasma samples
    • Bernini P., Bertini I., Luchinat C., Tenori L., Tognaccini A. The cardiovascular risk of healthy individuals studied by NMR metabonomics of plasma samples. J Proteome Res 2011, 10:4983-4992.
    • (2011) J Proteome Res , vol.10 , pp. 4983-4992
    • Bernini, P.1    Bertini, I.2    Luchinat, C.3    Tenori, L.4    Tognaccini, A.5
  • 55
    • 84155191018 scopus 로고    scopus 로고
    • Global host metabolic response to Plasmodium vivax infection: a 1H NMR based urinary metabonomic study
    • Sengupta A., Ghosh S., Basant A., Malusare S., Johri P., Pathak S., Sharma S., Sonawat H.M. Global host metabolic response to Plasmodium vivax infection: a 1H NMR based urinary metabonomic study. Malar J 2011, 10:384.
    • (2011) Malar J , vol.10 , pp. 384
    • Sengupta, A.1    Ghosh, S.2    Basant, A.3    Malusare, S.4    Johri, P.5    Pathak, S.6    Sharma, S.7    Sonawat, H.M.8
  • 57
    • 84860492297 scopus 로고    scopus 로고
    • The biology of personalized cancer medicine: facing individual complexities underlying hallmark capabilities
    • De Palma M., Hanahan D. The biology of personalized cancer medicine: facing individual complexities underlying hallmark capabilities. Mol Oncol 2012, 6:111-127.
    • (2012) Mol Oncol , vol.6 , pp. 111-127
    • De Palma, M.1    Hanahan, D.2
  • 58
    • 84893763297 scopus 로고    scopus 로고
    • Pharmacometabolomics: implications for clinical pharmacology and systems pharmacology
    • Kaddurah-Daouk R., Weinshilboum R.M. Pharmacometabolomics: implications for clinical pharmacology and systems pharmacology. Clin Pharmacol Ther 2014, 95:154-167.
    • (2014) Clin Pharmacol Ther , vol.95 , pp. 154-167
    • Kaddurah-Daouk, R.1    Weinshilboum, R.M.2
  • 59
    • 84872028171 scopus 로고    scopus 로고
    • New opportunities from the cancer metabolome
    • Aboud O.A., Weiss R.H. New opportunities from the cancer metabolome. Clin Chem 2013, 59:138-146.
    • (2013) Clin Chem , vol.59 , pp. 138-146
    • Aboud, O.A.1    Weiss, R.H.2
  • 61
    • 84858274873 scopus 로고    scopus 로고
    • Bridging the gap: moving predictive and prognostic assays from research to clinical use
    • Williams P.M., Lively T.G., Jessup J.M., Conley B.A. Bridging the gap: moving predictive and prognostic assays from research to clinical use. Clin Cancer Res 2012, 18:1531-1539.
    • (2012) Clin Cancer Res , vol.18 , pp. 1531-1539
    • Williams, P.M.1    Lively, T.G.2    Jessup, J.M.3    Conley, B.A.4
  • 62
    • 38949209075 scopus 로고    scopus 로고
    • NMR-based metabolic profiling and metabonomic approaches to problems in molecular toxicology
    • Coen M., Holmes E., Lindon J.C., Nicholson J.K. NMR-based metabolic profiling and metabonomic approaches to problems in molecular toxicology. Chem Res Toxicol 2008, 21:9-27.
    • (2008) Chem Res Toxicol , vol.21 , pp. 9-27
    • Coen, M.1    Holmes, E.2    Lindon, J.C.3    Nicholson, J.K.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.